Fundies.
English

Segment disclosures

Company overview

TSCAN THERAPEUTICS, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 16 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=tcrx:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301051000 USD20260812Open filing evidence
2026-01-01 – 2026-06-302033000 USD20260812Open filing evidence
2026-01-01 – 2026-03-31982000 USD20260506Open filing evidence
2025-01-01 – 2025-12-3110325000 USD20260304Open filing evidence
2025-07-01 – 2025-09-302511000 USD20251112Open filing evidence
2025-01-01 – 2025-09-307758000 USD20251112Open filing evidence
2025-04-01 – 2025-06-303076000 USD20260812Open filing evidence
2025-01-01 – 2025-06-305247000 USD20260812Open filing evidence
2025-01-01 – 2025-03-312171000 USD20260506Open filing evidence
2024-01-01 – 2024-12-312816000 USD20260304Open filing evidence
2024-07-01 – 2024-09-301049000 USD20251112Open filing evidence
2024-01-01 – 2024-09-302151000 USD20251112Open filing evidence
2024-04-01 – 2024-06-30536000 USD20250812Open filing evidence
2024-01-01 – 2024-06-301102000 USD20250812Open filing evidence
2024-01-01 – 2024-03-31566000 USD20250506Open filing evidence
2023-01-01 – 2023-12-3121049000 USD20250305Open filing evidence